Overview / Abstract: |
Target Audience Program Overview Learning Objectives Summarize evidence for the efficacy and safety of current agents for the treatment of CSU beyond first-line therapy |
Expiration |
Nov 30, 2025 |
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
0.50 AMA PRA Category 1 Credit™ |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Faculty David M. Lang, MD |
Sponsors / Supporters / Grant Providers |
Genentech, a member of the Roche Group. |
Keywords / Search Terms |
Relias LLC Relias LLC. FreeCME., chronic spontaneous urticaria (CSU) Free CE CME |